ALKERMES | ALKS - Trade Creditors



ALKERMES reported $99.21M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
AbbVie 2.94B 2.66B Dec/2024
Acadia Pharmaceuticals USD 20.1M 2M Jun/2025
ALKERMES USD 99.21M 39.37M Jun/2025
Amgen USD 18.03B 15.63B Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
Bristol-Myers Squibb USD 5.43B 1.42B Jun/2025
Eli Lilly USD 4.08B 633.7M Jun/2025
Gilead Sciences USD 582M 155M Jun/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
J&J USD 9.54B 766M Mar/2025
Malin Corporation EUR 0 500K Dec/2024
Merck USD 4.04B 261M Jun/2025
Neurocrine Biosciences 104.6M 5.4M Jun/2025
Otsuka Holdings JPY 209.84B 15.54B Jun/2025
Pfizer USD 5.17B 74M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025